albitiazolium , CAS No.321915-72-4

Item Number
A607496
Grouped product items
SKUSizeAvailabilityPrice Qty
A607496-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,334.90
A607496-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,001.90

Basic Description

SynonymsAlbitiazolium bromide | 321915-72-4 | SAR 97276 | Albitiazolium bromide [INN] | 3AC0AJ4ILP | SAR97276A | SAR-97276A | 1,12-BIS[4-METHYL-5-(2-HYDROXYETHYL)THIAZOL-3-IUM-3-YL]DODECANE DIBROMIDE | 3,3'-(Dodecan-1,12-diyl)bis(5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium) di
Specifications & PurityMoligand™
GradeMoligand™

Associated Targets(Human)

Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium vinckei petteri (380 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Names and Identifiers

IUPAC Name 2-[3-[12-[5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium-3-yl]dodecyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol;dibromide
INCHI InChI=1S/C24H42N2O2S2.2BrH/c1-21-23(13-17-27)29-19-25(21)15-11-9-7-5-3-4-6-8-10-12-16-26-20-30-24(14-18-28)22(26)2;;/h19-20,27-28H,3-18H2,1-2H3;2*1H/q+2;;/p-2
InChi Key AFJCGBHHSKAACR-UHFFFAOYSA-L
Canonical SMILES CC1=C(SC=[N+]1CCCCCCCCCCCC[N+]2=CSC(=C2C)CCO)CCO.[Br-].[Br-]
Isomeric SMILES CC1=C(SC=[N+]1CCCCCCCCCCCC[N+]2=CSC(=C2C)CCO)CCO.[Br-].[Br-]
Alternate CAS 321915-72-4
PubChem CID 11377022
MeSH Entry Terms 1,12-bis(4-methyl-5-(2-hydroxyethyl)thiazol-3-ium-3-yl)dodecane;1,12-bis(4-methyl-5-(2-hydroxyethyl)thiazol-3-ium-3-yl)dodecane dibromide;1,12-bisMHTD;albitiazolium;SAR 97276;SAR-97276;SAR97276

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Vial HJ, Wein S, Farenc C, Kocken C, Nicolas O, Ancelin ML, Bressolle F, Thomas A, Calas M.  (2004)  Prodrugs of bisthiazolium salts are orally potent antimalarials..  Proc Natl Acad Sci USA,  101  (43): (15458-63).  [PMID:15492221]
2. Nicolas O, Margout D, Taudon N, Wein S, Calas M, Vial HJ, Bressolle FM.  (2005)  Pharmacological properties of a new antimalarial bisthiazolium salt, T3, and a corresponding prodrug, TE3..  Antimicrob Agents Chemother,  49  (9): (3631-9).  [PMID:16127032]
3. Wein S, Maynadier M, Bordat Y, Perez J, Maheshwari S, Bette-Bobillo P, Tran Van Ba C, Penarete-Vargas D, Fraisse L, Cerdan R et al..  (2012)  Transport and pharmacodynamics of albitiazolium, an antimalarial drug candidate..  Br J Pharmacol,  166  (8): (2263-76).  [PMID:22471905]
4. Held J, Supan C, Salazar CLO, Tinto H, Bonkian LN, Nahum A, Sié A, Abdulla S, Cantalloube C, Djeriou E et al..  (2017)  Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patients..  Malar J,  16  (1): (188).  [PMID:28472957]

Solution Calculators